Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
etoposide phosphate
×
Clear all
Filters
3
NCT02964013
2025-10-14
KEYVIBE-001
Merck Sharp & Dohme LLC
Phase 1
Completed
474 enrolled
39 charts
NCT04924101
2025-07-23
KEYNOTE-B99
Merck Sharp & Dohme LLC
Phase 2
Completed
126 enrolled